MD financial statements and SEC filings
MD annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $1.91B | $208.81M | $165.39M | 10-K |
| 2024-12-31 | $2.01B | -$68.71M | -$99.07M | 10-K |
| 2023-12-31 | $1.99B | $7.32M | -$60.41M | 10-K |
| 2022-12-31 | $1.97B | $172.69M | $66.33M | 10-K |
| 2021-12-31 | $1.91B | $202.92M | $130.96M | 10-K |
| 2020-12-31 | $1.73B | $98.13M | -$796.49M | 10-K |
MD annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $2.25B | $1.38B | $865.85M | 10-Q |
| 2024-12-31 | $2.15B | $1.39B | $764.94M | 10-K |
| 2023-12-31 | $2.22B | $1.37B | $849.06M | 10-K |
| 2022-12-31 | $2.35B | $1.46B | $891.63M | 10-K |
| 2021-12-31 | $2.72B | $1.83B | $896.69M | 10-K |
| 2020-12-31 | $3.35B | $2.60B | $747.72M | 10-K |
MD annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $271.09M | -$18.46M | -$107.49M | 10-K |
| 2024-12-31 | $206.57M | -$22.02M | -$14.48M | 10-K |
| 2023-12-31 | $137.32M | -$33.33M | -$25.71M | 10-K |
| 2022-12-31 | $166.94M | -$29.71M | -$487.55M | 10-K |
| 2021-12-31 | $76.74M | -$32.25M | -$760.12M | 10-K |
| 2020-12-31 | $204.62M | -$28.79M | -$4.16M | 10-K |